Spotlight on the Low dose Rosiglitazone/ Metformin Combination In Prevention of Type 2 Diabetes

Diabetes mellitus is one of the major challenges to public health with global prevalence of 6.6% (285 million) and annual cost of 376 billion US dollars. Pharmacological and non pharmacological interventions which target either to delay the onset of diabetes or to prevent its complications have been...

Full description

Bibliographic Details
Main Author: Muhammad Abdul Hadi
Format: Article
Language:English
Published: Archives of Global Professionals 2010-10-01
Series:Archives of Pharmacy Practice
Subjects:
Online Access:http://www.archivepp.com/Resources/Files/22102010104335868.pdf